{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:36:56Z","timestamp":1793223416583,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T00:00:00Z","timestamp":1525046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41431-018-0140-4","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T06:54:14Z","timestamp":1524725654000},"page":"1319-1328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Identification of variants in pleiotropic genes causing \u201cisolated\u201d premature ovarian insufficiency: implications for medical practice"],"prefix":"10.1038","volume":"26","author":[{"given":"Elena J.","family":"Tucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia R.","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorjana","family":"Robevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"van den Bergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,30]]},"reference":[{"key":"140_CR1","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/humrep\/dev021","volume":"30","author":"K Haller-Kikkatalo","year":"2015","unstructured":"Haller-Kikkatalo K, Uibo R, Kurg A, Salumets A. The prevalence and phenotypic characteristics of spontaneous premature ovarian failure: a general population registry-based study. Hum Reprod. 2015;30:1229\u201338.","journal-title":"Hum Reprod"},{"key":"140_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1210\/er.2016-1047","volume":"37","author":"EJ Tucker","year":"2016","unstructured":"Tucker EJ, Grover SR, Bachelot A, Touraine P, Sinclair AH. Premature ovarian insufficiency: new perspectives on genetic cause and phenotypic spectrum. Endocr Rev. 2016;37:609\u201335.","journal-title":"Endocr Rev"},{"key":"140_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1105-y","volume":"17","author":"S Eggers","year":"2016","unstructured":"Eggers S, Sadedin S, van den Bergen JA, et al. Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort. Genome Biol. 2016;17:243.","journal-title":"Genome Biol"},{"key":"140_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/hmg\/ddi482","volume":"15","author":"R Varon","year":"2006","unstructured":"Varon R, Dutrannoy V, Weikert G, et al. Mild Nijmegen breakage syndrome phenotype due to alternative splicing. Hum Mol Genet. 2006;15:679\u201389.","journal-title":"Hum Mol Genet"},{"key":"140_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0191-x","volume":"7","author":"SP Sadedin","year":"2015","unstructured":"Sadedin SP, Dashnow H, James PA, et al. Cpipe: a shared variant detection pipeline designed for diagnostic settings. Genome Med. 2015;7:68.","journal-title":"Genome Med"},{"key":"140_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"C Genomes Project","year":"2015","unstructured":"Genomes Project C, Auton A, Brooks LD, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374.","journal-title":"Nature"},{"key":"140_CR7","unstructured":"ESP NGESP. Exome variant server. 2015. http:\/\/evs.gs.washington.edu\/EVS\/ ."},{"key":"140_CR8","unstructured":"ExAC EAC. Exome aggregation consortium. 2015. http:\/\/exac.broadinstitute.org ."},{"key":"140_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"140_CR10","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1210\/jc.2009-2628","volume":"95","author":"KH Chrzanowska","year":"2010","unstructured":"Chrzanowska KH, Szarras-Czapnik M, Gajdulewicz M, et al. High prevalence of primary ovarian insufficiency in girls and young women with Nijmegen breakage syndrome: evidence from a longitudinal study. J Clin Endocrinol Metab. 2010;95:3133\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"140_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ijc.20239","volume":"111","author":"J Steffen","year":"2004","unstructured":"Steffen J, Varon R, Mosor M, et al. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int J Cancer. 2004;111:67\u201371.","journal-title":"Int J Cancer"},{"key":"140_CR12","first-page":"3570","volume":"61","author":"R Varon","year":"2001","unstructured":"Varon R, Reis A, Henze G, von Einsiedel HG, Sperling K, Seeger K. Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL). Cancer Res. 2001;61:3570\u20132.","journal-title":"Cancer Res"},{"key":"140_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0092-8674(00)81174-5","volume":"93","author":"R Varon","year":"1998","unstructured":"Varon R, Vissinga C, Platzer M, et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell. 1998;93:467\u201376.","journal-title":"Cell"},{"key":"140_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0092-8674(00)81175-7","volume":"93","author":"JP Carney","year":"1998","unstructured":"Carney JP, Maser RS, Olivares H, et al. The hMre11\/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell. 1998;93:477\u201386.","journal-title":"Cell"},{"key":"140_CR15","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/S0960-9822(01)00267-6","volume":"11","author":"V Ranganathan","year":"2001","unstructured":"Ranganathan V, Heine WF, Ciccone DN, et al. Rescue of a telomere length defect of Nijmegen breakage syndrome cells requires NBS and telomerase catalytic subunit. Curr Biol. 2001;11:962\u20136.","journal-title":"Curr Biol"},{"key":"140_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrm3546","volume":"14","author":"Y Shiloh","year":"2013","unstructured":"Shiloh Y, Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol. 2013;14:197\u2013210.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"140_CR17","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1128\/MCB.21.6.2184-2191.2001","volume":"21","author":"A Desai-Mehta","year":"2001","unstructured":"Desai-Mehta A, Cerosaletti KM, Concannon P. Distinct functional domains of nibrin mediate Mre11 binding, focus formation, and nuclear localization. Mol Cell Biol. 2001;21:2184\u201391.","journal-title":"Mol Cell Biol"},{"key":"140_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1269\/jrr.45.473","volume":"45","author":"J Kobayashi","year":"2004","unstructured":"Kobayashi J. Molecular mechanism of the recruitment of NBS1\/hMRE11\/hRAD50 complex to DNA double-strand breaks: NBS1 binds to gamma-H2AX through FHA\/BRCT domain. J Radiat Res. 2004;45:473\u20138.","journal-title":"J Radiat Res"},{"key":"140_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0960-9822(01)00019-7","volume":"11","author":"J Zhu","year":"2001","unstructured":"Zhu J, Petersen S, Tessarollo L, Nussenzweig A. Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr Biol. 2001;11:105\u20139.","journal-title":"Curr Biol"},{"key":"140_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/86920","volume":"27","author":"RS Maser","year":"2001","unstructured":"Maser RS, Zinkel R, Petrini JH. An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele. Nat Genet. 2001;27:417\u201321.","journal-title":"Nat Genet"},{"key":"140_CR21","first-page":"19","volume":"7","author":"E Ormerod","year":"2009","unstructured":"Ormerod E, Belengeanu V, Stoian M, et al. Nijmegen breakage syndrome: clinico-cytogenetic pattern. J Pediatr. 2009;7:19\u201324.","journal-title":"J Pediatr"},{"key":"140_CR22","doi-asserted-by":"publisher","first-page":"e0118001","DOI":"10.1371\/journal.pone.0118001","volume":"10","author":"H Zhang","year":"2015","unstructured":"Zhang H, Dai L, Chen N, et al. Fifteen novel EIF2B1-5 mutations identified in Chinese children with leukoencephalopathy with vanishing white matter and a long term follow-up. PLoS ONE. 2015;10:e0118001.","journal-title":"PLoS ONE"},{"key":"140_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/ng764","volume":"29","author":"PA Leegwater","year":"2001","unstructured":"Leegwater PA, Vermeulen G, Konst AA, et al. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet. 2001;29:383\u20138.","journal-title":"Nat Genet"},{"key":"140_CR24","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1212\/01.WNL.0000123259.67815.DB","volume":"62","author":"A Fogli","year":"2004","unstructured":"Fogli A, Schiffmann R, Bertini E, et al. The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology. 2004;62:1509\u201317.","journal-title":"Neurology"},{"key":"140_CR25","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1042\/BST0331487","volume":"33","author":"GD Pavitt","year":"2005","unstructured":"Pavitt GD. eIF2B, a mediator of general and gene-specific translational control. Biochem Soc Trans. 2005;33:1487\u201392.","journal-title":"Biochem Soc Trans"},{"key":"140_CR26","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/S0021-9258(18)60596-4","volume":"263","author":"AG Rowlands","year":"1988","unstructured":"Rowlands AG, Panniers R, Henshaw EC. The catalytic mechanism of guanine nucleotide exchange factor action and competitive inhibition by phosphorylated eukaryotic initiation factor 2. J Biol Chem. 1988;263:5526\u201333.","journal-title":"J Biol Chem"},{"key":"140_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ana.10112","volume":"51","author":"MS Knaap van der","year":"2002","unstructured":"van der Knaap MS, Leegwater PA, Konst AA, et al. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol. 2002;51:264\u201370.","journal-title":"Ann Neurol"},{"key":"140_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/mrdd.20104","volume":"12","author":"JC Pronk","year":"2006","unstructured":"Pronk JC, van Kollenburg B, Scheper GC, van der Knaap MS. Vanishing white matter disease: a review with focus on its genetics. Ment Retard Dev Disabil Res Rev. 2006;12:123\u20138.","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"140_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1042\/BST0340022","volume":"34","author":"A Fogli","year":"2006","unstructured":"Fogli A, Boespflug-Tanguy O. The large spectrum of eIF2B-related diseases. Biochem Soc Trans. 2006;34:22\u20139.","journal-title":"Biochem Soc Trans"},{"key":"140_CR30","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1086\/375404","volume":"72","author":"A Fogli","year":"2003","unstructured":"Fogli A, Rodriguez D, Eymard-Pierre E, et al. Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet. 2003;72:1544\u201350.","journal-title":"Am J Hum Genet"},{"key":"140_CR31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/humu.20904","volume":"30","author":"M Warcoin","year":"2009","unstructured":"Warcoin M, Lespinasse J, Despouy G, et al. Fertility defects revealing germline biallelic nonsense NBN mutations. Hum Mutat. 2009;30:424\u201330.","journal-title":"Hum Mutat"},{"key":"140_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1399-0004.1986.tb01892.x","volume":"30","author":"P Maraschio","year":"1986","unstructured":"Maraschio P, Peretti D, Lambiase S, et al. A new chromosome instability disorder. Clin Genet. 1986;30:353\u201365.","journal-title":"Clin Genet"},{"key":"140_CR33","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1212\/WNL.0b013e3182749edc","volume":"79","author":"L Ghezzi","year":"2012","unstructured":"Ghezzi L, Scarpini E, Rango M, et al. A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation. Neurology. 2012;79:2077\u20138.","journal-title":"Neurology"},{"key":"140_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10048-011-0284-7","volume":"12","author":"T Matsukawa","year":"2011","unstructured":"Matsukawa T, Wang X, Liu R, et al. Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2, EIF2B3, and EIF2B5. Neurogenetics. 2011;12:259\u201361.","journal-title":"Neurogenetics"},{"key":"140_CR35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/ana.10339","volume":"52","author":"A Fogli","year":"2002","unstructured":"Fogli A, Wong K, Eymard-Pierre E, et al. Cree leukoencephalopathy and CACH\/VWM disease are allelic at the EIF2B5 locus. Ann Neurol. 2002;52:506\u201310.","journal-title":"Ann Neurol"},{"key":"140_CR36","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/humu.21535","volume":"32","author":"R Liu","year":"2011","unstructured":"Liu R, van der Lei HD, Wang X, et al. Severity of vanishing white matter disease does not correlate with deficits in eIF2B activity or the integrity of eIF2B complexes. Hum Mutat. 2011;32:1036\u201345.","journal-title":"Hum Mutat"},{"key":"140_CR37","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1093\/brain\/awp171","volume":"132","author":"P Labauge","year":"2009","unstructured":"Labauge P, Horzinski L, Ayrignac X. et al. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. Brain. 2009;132:2161\u20139.","journal-title":"Brain"},{"key":"140_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1472-6874-4-8","volume":"4","author":"A Fogli","year":"2004","unstructured":"Fogli A, Gauthier-Barichard F, Schiffmann R, et al. Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure. BMC Women\u2019s Health. 2004;4:8.","journal-title":"BMC Women\u2019s Health"},{"key":"140_CR39","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/jama.2014.369","volume":"311","author":"JM Kocarnik","year":"2014","unstructured":"Kocarnik JM, Fullerton SM. Returning pleiotropic results from genetic testing to patients and research participants. JAMA. 2014;311:795\u20136.","journal-title":"JAMA"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0140-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0140-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0140-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:42:19Z","timestamp":1684618939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-018-0140-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,30]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["140"],"URL":"https:\/\/doi.org\/10.1038\/s41431-018-0140-4","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,30]]},"assertion":[{"value":"2 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}